Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11001571 Bipyrazole derivatives as JAK inhibitors

Patent 11001571 was granted and assigned to Incyte on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Ganfeng Cao0

Ding-Quan Qian0

Jincong Zhuo0

Qun Li0

Song Mei0

Yongchun Pan0

Yun-Long Li0

Zhongjiang Jia0

Date of Patent

May 11, 2021

Patent Application Number

16555620

Date Filed

August 29, 2019

Patent Citations

US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

0

Patent Citations Received

US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo

0

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders

0

US Patent 11905275 Bipyrazole derivatives as JAK inhibitors

0

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

0

US Patent 11591318 Bipyrazole derivatives as JAK inhibitors

0

US Patent 11685731 Processes of preparing a JAK1 inhibitor

0

Patent Primary Examiner

Patent abstract

The present invention provides compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11001571 Bipyrazole derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool